• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4601863)   Today's Articles (3442)   Subscriber (49366)
For: Wang D, Chong VC, Chong WS, Oon HH. A Review on Pityriasis Rubra Pilaris. Am J Clin Dermatol 2018;19:377-90. [PMID: 29302927 DOI: 10.1007/s40257-017-0338-1] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Number Cited by Other Article(s)
1
Vieira Granja B, Amoedo P, Gomes NP, Costa C, Azevedo F, Magina S. Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab. An Bras Dermatol 2024;99:642-644. [PMID: 38653608 DOI: 10.1016/j.abd.2023.07.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2023] [Revised: 07/09/2023] [Accepted: 07/10/2023] [Indexed: 04/25/2024]  Open
2
Koroneos G, Nicolopoulos J, Dolianitis C. Risankizumab for the treatment of pityriasis rubra pilaris postanaplastic large cell lymphoma. JAAD Case Rep 2024;48:108-111. [PMID: 38813065 PMCID: PMC11134539 DOI: 10.1016/j.jdcr.2024.03.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2024]  Open
3
Shams RB, Rubinstein DE, Sayed CJ. Surgical Management of Severe Cicatricial Ectropion Secondary to Pityriasis Rubra Pilaris. Dermatol Surg 2024:00042728-990000000-00826. [PMID: 38820437 DOI: 10.1097/dss.0000000000004258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2024] [Indexed: 06/02/2024]
4
Moledina M, Davison S, Malik A. Ophthalmic complication of pityriasis rubra pilaris. BMJ Case Rep 2024;17:e256445. [PMID: 38806396 DOI: 10.1136/bcr-2023-256445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2024]  Open
5
Chandy RJ, Chokshi A, Tan I, Feldman SR. Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review. J Cutan Med Surg 2024;28:269-275. [PMID: 38549359 DOI: 10.1177/12034754241238735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/31/2024]
6
Bobotsis R, Brathwaite S, Eshtiaghi P, Rodriguez-Bolanos F, Doiron P. HIV: Inflammatory dermatoses. Clin Dermatol 2024;42:169-179. [PMID: 38142786 DOI: 10.1016/j.clindermatol.2023.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2023]
7
Joshi TP, Duvic M. Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options. Am J Clin Dermatol 2024;25:243-259. [PMID: 38159213 DOI: 10.1007/s40257-023-00836-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/04/2023] [Indexed: 01/03/2024]
8
Montero-Menárguez J, Amat Samaranch V, Puig Sanz L, Ruiz-Villaverde R, Arias-Santiago S, Larrea García M, Ruiz Genao D, Ferrán M, Schneller-Pavelescu L, Romero Ferreiro C, Rivera Díaz R. Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish Patients. ACTAS DERMO-SIFILIOGRAFICAS 2024:S0001-7310(24)00161-3. [PMID: 38401879 DOI: 10.1016/j.ad.2024.02.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2023] [Revised: 12/13/2023] [Accepted: 02/06/2024] [Indexed: 02/26/2024]  Open
9
Blicharz L, Czuwara J, Rudnicka L, Torrelo A. Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications. Clin Rev Allergy Immunol 2023;65:377-402. [PMID: 38103162 PMCID: PMC10847199 DOI: 10.1007/s12016-023-08971-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/24/2023] [Indexed: 12/17/2023]
10
Armillas-Lliteras L, Iglesias-Sancho M, Altemir A, Moreno Romero JA. Pityriasis rubra pilaris induced by topical use of imiquimod 5. An Bras Dermatol 2023;98:884-886. [PMID: 37394296 PMCID: PMC10589495 DOI: 10.1016/j.abd.2022.04.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Revised: 04/09/2022] [Accepted: 04/11/2022] [Indexed: 07/04/2023]  Open
11
Ramesh H, Somashekhar S, Kanathur S. Lichens in dermatology. Indian J Dermatol Venereol Leprol 2023;89:908-915. [PMID: 37067120 DOI: 10.25259/ijdvl_794_2021] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2021] [Accepted: 06/29/2022] [Indexed: 03/30/2023]
12
Ishikawa Y, Ajima S, Hashizume H. Pityriasis rubra pilaris with simultaneous emergence of human herpesvirus-6 reactivation in a patient with drug-induced hypersensitivity syndrome. J Dermatol 2023;50:e368-e369. [PMID: 37469202 DOI: 10.1111/1346-8138.16877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 05/02/2023] [Accepted: 06/15/2023] [Indexed: 07/21/2023]
13
Potestio L, Martora F, Villani A, Megna M, Ruggiero A. Comment on: 'Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination' by Gambichler. J Eur Acad Dermatol Venereol 2023;37:e1196-e1197. [PMID: 37326210 DOI: 10.1111/jdv.19264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Accepted: 06/12/2023] [Indexed: 06/17/2023]
14
Guevara M, Mafla M, Miño C. Atypical Mal de Meleda in a Hispanic Patient. Case Rep Dermatol Med 2023;2023:6640311. [PMID: 37744084 PMCID: PMC10513804 DOI: 10.1155/2023/6640311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 09/08/2023] [Accepted: 09/09/2023] [Indexed: 09/26/2023]  Open
15
Abduljawad M, Alsharif TH, Gronfula AG, Magadmi TK, Khayat LI, Fageeh SM, Almuallim AA, Mohammad MA, Albadri A. The Effectiveness of Anti-Interleukin-17A Treatment for Pityriasis Rubra Pilaris: A Systematic Review. Cureus 2023;15:e41125. [PMID: 37519579 PMCID: PMC10382908 DOI: 10.7759/cureus.41125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/29/2023] [Indexed: 08/01/2023]  Open
16
Al Khalifa N, Alsabbagh M, Raees M, Aljufairi E. Misdiagnosed Pityriasis Rubra Pilaris Successfully Managed With Isotretinoin: A Case Series. Cureus 2023;15:e38657. [PMID: 37168410 PMCID: PMC10166574 DOI: 10.7759/cureus.38657] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/04/2023] [Indexed: 05/13/2023]  Open
17
Zhang LW, Wang WJ, Fu LX, Lu YH, Chen T, Xu RH. Pityriasis rubra pilaris following inactivated SARS-CoV-2 vaccine (CoronaVac). J Eur Acad Dermatol Venereol 2023;37:e287-e288. [PMID: 36504416 DOI: 10.1111/jdv.18768] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 11/09/2022] [Indexed: 11/23/2022]
18
Saad M, Spurr A, Lipson J. Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report. SAGE Open Med Case Rep 2023;11:2050313X231160927. [PMID: 37009550 PMCID: PMC10064474 DOI: 10.1177/2050313x231160927] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/31/2023]  Open
19
Balak DMW, Rissmann R. Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic wave. Br J Dermatol 2022;187:633-634. [PMID: 35996840 PMCID: PMC10015986 DOI: 10.1111/bjd.21813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2022] [Accepted: 07/26/2022] [Indexed: 11/29/2022]
20
Albrakati BA, Alshareef IA, Alhawsawi WK, Al Hawsawi KA. Atypical Juvenile Pityriasis Rubra Pilaris: A Case Report of Early Onset With Late Diagnosis. Cureus 2022;14:e30234. [DOI: 10.7759/cureus.30234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/12/2022] [Indexed: 11/05/2022]  Open
21
Nishimura M, Kondo M, Habe K, Hayashi A, Yamanaka K. Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris. Clin Case Rep 2022;10:e6413. [PMID: 36245447 PMCID: PMC9540577 DOI: 10.1002/ccr3.6413] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Revised: 09/17/2022] [Accepted: 09/20/2022] [Indexed: 11/06/2022]  Open
22
Muacevic A, Adler JR. Physiotherapy Management of an Adolescent With Pityriasis Rubra Pilaris Along With Rickets. Cureus 2022;14:e30518. [PMID: 36415347 PMCID: PMC9674203 DOI: 10.7759/cureus.30518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2022] [Accepted: 10/20/2022] [Indexed: 01/25/2023]  Open
23
Kranyak A, Shuler M. Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient. JAAD Case Rep 2022;27:55-57. [PMID: 36035459 PMCID: PMC9399409 DOI: 10.1016/j.jdcr.2022.07.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]  Open
24
Shakshouk H, Erickson LA, Johnson EF, Lehman JS. Updates and Proposed Diagnostic Approach to Psoriasiform Dermatoses. Adv Anat Pathol 2022;29:263-274. [PMID: 35180737 DOI: 10.1097/pap.0000000000000333] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
25
Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Dujmovic-Hasanbegovic K, Prpic-Massari L. Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine. Dermatol Ther 2022;35:e15791. [PMID: 36029037 PMCID: PMC9538535 DOI: 10.1111/dth.15791] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Revised: 07/27/2022] [Accepted: 08/24/2022] [Indexed: 11/29/2022]
26
Okladnikova EV, Kotova KV, Khorzhevskii V, Ruksha TG. Pityriasis rubra pilaris (Devergie's disease) in a COVID-19 patient. VESTNIK DERMATOLOGII I VENEROLOGII 2022. [DOI: 10.25208/vdv1333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]  Open
27
Zhao Z, Zhang X, Wang R, Wang Y, Gong L, Li C. Vaccine‐induced erythrodermic psoriasis in a child successfully treated with secukinumab: A case report and brief literature review. Dermatol Ther 2022;35:e15684. [PMID: 35789520 DOI: 10.1111/dth.15684] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2022] [Revised: 06/24/2022] [Accepted: 07/03/2022] [Indexed: 11/27/2022]
28
Allegue F, Fachal C, Iglesias B, Zulaica A. [Translated article] Facial Discoid Dermatosis: A New Variant of Pityriasis Rubra Pilaris? ACTAS DERMO-SIFILIOGRAFICAS 2022. [DOI: 10.1016/j.ad.2022.05.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]  Open
29
Gambichler T, Scheel CH, Arafat Y, Kautz O, Boms S. Erythrodermic pityriasis rubra pilaris after SASRS-CoV-2 vaccination with concomitant COVID-19 infection. J Eur Acad Dermatol Venereol 2022;36:e675-e676. [PMID: 35536694 PMCID: PMC9347623 DOI: 10.1111/jdv.18214] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Accepted: 05/04/2022] [Indexed: 11/29/2022]
30
DeBiasio C, Cyr J, Ayroud Y, Glassman SJ. A case of classic adult pityriasis rubra pilaris successfully treated with a combination of acitretin and ustekinumab: A case report. SAGE Open Med Case Rep 2022;10:2050313X221093453. [PMID: 35465019 PMCID: PMC9021576 DOI: 10.1177/2050313x221093453] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
31
Ajebo EM, Howard JD, Anand D, Davis LS. Pityriasis Rubra Pilaris Potentially Triggered by mRNA-1273 COVID Vaccine. JAAD Case Rep 2022;23:114-116. [PMID: 35465138 PMCID: PMC9013576 DOI: 10.1016/j.jdcr.2022.03.013] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
32
Banjar TA, Abdulwahab RA, Al Hawsawi KA. Confluent and Reticulated Papillomatosis of Gougerot and Carteaud: A Case Report and Review of the Literature. Cureus 2022;14:e24557. [PMID: 35651451 PMCID: PMC9138193 DOI: 10.7759/cureus.24557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/28/2022] [Indexed: 11/23/2022]  Open
33
Criado P, Ianhez M, Rocha P, Miot H. Pityriasis rubra pilaris (type I) following ChAdOx1 COVID‐19 vaccine: report of two cases with successful treatment with oral isotretinoin. J Eur Acad Dermatol Venereol 2022;36:e508-e510. [PMID: 35278239 PMCID: PMC9114897 DOI: 10.1111/jdv.18055] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2022] [Revised: 02/02/2022] [Accepted: 03/04/2022] [Indexed: 11/28/2022]
34
Anselmo F, Driscoll MS. Deleterious side effects of nutritional supplements. Clin Dermatol 2021;39:745-756. [PMID: 34785002 DOI: 10.1016/j.clindermatol.2021.05.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
35
Shao S, Chen J, Swindell WR, Tsoi LC, Xing X, Ma F, Uppala R, Sarkar MK, Plazyo O, Billi AC, Wasikowski R, Smith KM, Honore P, Scott VE, Maverakis E, Kahlenberg JM, Wang G, Ward NL, Harms PW, Gudjonsson JE. Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris. JCI Insight 2021;6:e151911. [PMID: 34491907 PMCID: PMC8564909 DOI: 10.1172/jci.insight.151911] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Accepted: 09/03/2021] [Indexed: 02/02/2023]  Open
36
Sánchez-Cárdenas CD, Vega-Memije ME, Flores-Gavilán P, Romero M, Arenas R, Sánchez RL. Disseminated and recurrent infundibulofolliculitis in children in Mexico. Pediatr Dermatol 2021;38:1233-1236. [PMID: 34515382 DOI: 10.1111/pde.14803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
37
Sahni MK, Roy K, Asati DP, Khurana U. An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris. INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE 2021;32:261-264. [PMID: 34420983 DOI: 10.3233/jrs-210048] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
38
SnapshotDx Quiz: August 2021. J Invest Dermatol 2021. [PMID: 34303470 DOI: 10.1016/j.jid.2021.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
39
Allegue F, Fachal C, Iglesias B, Zulaica A. Facial Discoid Dermatosis: A New Variant of Pityriasis Rubra Pilaris? ACTAS DERMO-SIFILIOGRAFICAS 2021;113:728-731. [PMID: 33992621 DOI: 10.1016/j.ad.2021.01.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2020] [Revised: 12/20/2020] [Accepted: 01/11/2021] [Indexed: 11/25/2022]  Open
40
Lamberg O, Cao S, Sabater-Geib S, Lowe L, Elder J. A case of recurrent and paraneoplastic pityriasis rubra pilaris. JAAD Case Rep 2021;12:74-76. [PMID: 34041337 PMCID: PMC8141418 DOI: 10.1016/j.jdcr.2021.04.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
41
Kettering C, Khosravi H, Ortiz C, English JC. Drug survival of systemic and biologic monotherapy treatments for pityriasis rubra pilaris: A retrospective observational study. J Am Acad Dermatol 2021;86:1142-1143. [PMID: 33894320 DOI: 10.1016/j.jaad.2021.04.041] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2021] [Revised: 03/29/2021] [Accepted: 04/09/2021] [Indexed: 10/21/2022]
42
Ghatnekar S, Shah N, Min MS, Mazori DR, LaChance AH, Vleugels RA, Nambudiri VE. Clinical features and eosinophilia in pityriasis rubra pilaris: A multicenter cohort. J Am Acad Dermatol 2021;86:907-909. [PMID: 33771592 DOI: 10.1016/j.jaad.2021.03.043] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2021] [Revised: 03/12/2021] [Accepted: 03/16/2021] [Indexed: 11/29/2022]
43
Kwak RB, Hafeez F, Lian C, Nambudiri VE. Paraneoplastic pityriasis rubra pilaris heralding onset of new hematologic malignancy. Am J Hematol 2021;96:272-274. [PMID: 32501564 DOI: 10.1002/ajh.25897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 05/25/2020] [Accepted: 05/28/2020] [Indexed: 11/05/2022]
44
Mahlangeni GM, Tod BM, Jordaan HF, Schneider JW. Clinicopathological Features of Seborrheic-Like Dermatitis in HIV-Infected Adults: A Single Institutional Descriptive Cross-Sectional Study. Am J Dermatopathol 2021;43:27-34. [PMID: 32379092 DOI: 10.1097/dad.0000000000001670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
45
Gisondi P, Bellinato F, Girolomoni G. Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks. J Clin Med 2020;9:E3594. [PMID: 33171581 PMCID: PMC7695211 DOI: 10.3390/jcm9113594] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2020] [Revised: 11/03/2020] [Accepted: 11/05/2020] [Indexed: 12/13/2022]  Open
46
Amat-Samaranch V, Cubiró X, Tubau C, Garcia-Melendo C, Puig L. Response of pityriasis rubra pilaris to brodalumab after primary failure to ustekinumab. Int J Dermatol 2020;60:e112-e114. [PMID: 33128453 DOI: 10.1111/ijd.15219] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2020] [Accepted: 09/02/2020] [Indexed: 11/30/2022]
47
Liang JY, Ye RX, Tian X, Zhang SQ, Zhang XB. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review. Dermatol Ther 2020;33:e14097. [PMID: 32725719 DOI: 10.1111/dth.14097] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2020] [Revised: 07/20/2020] [Accepted: 07/22/2020] [Indexed: 11/29/2022]
48
Camela E, Miano C, Di Caterino P, Lo Presti M, De Fata Salvatores G, Fabbrocini G, Megna M. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review. Dermatol Ther 2020;33:e14223. [PMID: 32820849 DOI: 10.1111/dth.14223] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 08/07/2020] [Accepted: 08/17/2020] [Indexed: 01/16/2023]
49
Chin LD, Parvinnejad N, Haber RM. Pityriasis in dermatology: an updated review. Int J Dermatol 2020;60:141-158. [PMID: 32783190 DOI: 10.1111/ijd.15097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Revised: 05/30/2020] [Accepted: 07/14/2020] [Indexed: 11/30/2022]
50
Sander M, Sander M. Acral pityriasis rubra pilaris. CMAJ 2020;192:E118. [PMID: 32015081 DOI: 10.1503/cmaj.190961] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
PrevPage 1 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA